目的 研究康婦消炎栓聯(lián)合宮炎平滴丸治療盆腔炎性疾病所致慢性盆腔痛的臨床療效。方法 選取陜西省第四人民醫(yī)院2018年1月-2018年12月收治的盆腔炎性疾病所致慢性盆腔痛患者120例，隨機(jī)分為對(duì)照組和治療組，每組各60例。對(duì)照組口服宮炎平滴丸，20丸/次，3次/d。治療組在對(duì)照組的基礎(chǔ)上直腸給予康婦消炎栓，1枚/次，早晚各1次。依據(jù)患者病情，平均治療8周觀察療效，經(jīng)期不停藥。觀察兩組患者臨床療效和隨訪結(jié)果，同時(shí)比較治療前后兩組患者陰道分泌物白細(xì)胞、血C反應(yīng)蛋白（CRP）、血清降鈣素原（PCT）、紅細(xì)胞沉降率（ESR）、淋病奈瑟菌和臨床癥狀VAS。結(jié)果 治療后，對(duì)照組臨床有效率為65.7%，治療組臨床有效率為85.0%，兩組比較差異有統(tǒng)計(jì)學(xué)意義（P<0.05）。隨訪3個(gè)月后，對(duì)照組臨床有效率為55.0%，復(fù)發(fā)率為10.0%，治療組臨床有效率為81.6%，復(fù)發(fā)率為3.3%，隨訪后兩組臨床有效率和復(fù)發(fā)率比較差異具有統(tǒng)計(jì)學(xué)意義（P<0.05）。治療后，兩組患者陰道分泌物白細(xì)胞、血CRP、血清PCT、ESR、淋病奈瑟菌等水平均顯著降低（P<0.05），且治療組明顯低于對(duì)照組（P<0.05）。治療后，兩組患者臨床癥狀VAS評(píng)分明顯降低（P<0.05），且治療組明顯低于對(duì)照組（P<0.05）。結(jié)論 康婦消炎栓聯(lián)合宮炎平滴丸治療盆腔炎性疾病所致慢性盆腔痛療效顯著，副作用小，復(fù)發(fā)率低。

Objective To study the curative effect of Kangfu Xiaoyan Suppository combined with Gongyanping Dropping Pills in treatment of chronic pelvic pain caused by pelvic inflammatory disease. Methods Patients (120 cases) with chronic pelvic pain caused by pelvic inflammatory disease in the Fourth People's Hospital of Shaanxi from January 2018 to December 2018 were randomly divided into control and treatment groups, and each group had 60 cases. Patients in the control group were po administered with Gongyanping Dropping Pills, 20 pills/time, three times daily. Patients in the treatment group were rectally administered with Kangfu Xiaoyan Suppository on the basis of the control group, once 1 suppository, twice daily. According to the patient's condition, the average treatment lasted 8 weeks to observe the curative effect, and the drug was not stopped during menstruation. After treatment, the clinical efficacy and follow up results were evaluated, and the vaginal secretion white blood cells, blood CRP, serum PCT, ESR, neisseria gonorrhoeae and VAS of clinical symptoms in two groups before and after treatment were compared. Results After treatment, the clinical efficacy in the control group was 65.7%, which was significantly lower than 85.0% in the treatment group, and there were differences between two groups (P<0.05). After 3 months of follow-up, the clinical efficacy in the control group was 55%, the recurrence rate was 10.0%, but the clinical efficacy in the treatment group was 81.6%, the recurrence rate was 3.3%, and there were differences between two groups (P<0.05). After treatment, the vaginal secretion white blood cells, blood CRP, serum PCT, ESR, neisseria gonorrhoeae in two groups were significantly decreased (P<0.05), and these indexes in the treatment group were significantly lower than that in the control group (P<0.05). After treatment, the VAS of clinical symptoms in two groups were significantly decreased (P<0.05), and which in the treatment group were significantly lower than that in the control group (P<0.05). Conclusion Kangfu Xiaoyan Suppository combined with Gongyanping Dropping Pills in treatment of chronic pelvic pain caused by pelvic inflammatory disease has significant efficacy with less side effects and low recurrence rate.

R984